Biograph

Biograph has quickly become one of the most recognized names in preventive health since opening in New York in May 2025, co-founded by Dr. Peter Attia and tech entrepreneur John Hering. The clinic collects over 1,000 datapoints across 30+ assessments in a single day, including full-body MRI, CT coronary angiography, DEXA, VO2 max, and advanced blood panels. The team's clinical pedigree and the depth of the diagnostic protocol have earned significant media attention and strong early patient feedback, with over 15% of members reportedly uncovering urgent or previously unknown health issues. The diagnostic experience is thorough, well-organized, and delivered with a level of clinical rigor that reflects Attia's evidence-based philosophy. The primary limitation is scope: Biograph is purely diagnostic, offering no therapeutic interventions, regenerative treatments, or ongoing clinical programs. The value proposition centers entirely on early detection and risk assessment. At up to $15,000, the pricing is premium for a single-day assessment, and as a very new operation, longitudinal outcome data is still being built. For individuals who want the most comprehensive diagnostic snapshot available and value the clinical perspective of Attia's team, Biograph delivers an impressive and data-rich experience.